Northwire Canada EditionWednesday, July 15, 2026
Sign inSubscribe
Northwire
⌕
EFF 0.030 +20.0% W 0.500 +1.0% RDG 0.160 +0.0% ARIC 0.780 +4.0% VROY 3.44 +5.2% ROCK 3.81 +3.0% APMI 0.120 +0.0% EM 3.58 −4.8% ALS 66.04 +6.8% MEK 0.065 +44.4% TLO 6.00 +13.0% ADE 0.045 −66.7% FAIR 0.060 +33.3% SVRS 0.420 −2.3% RES 0.050 +42.9% CYG 0.120 +0.0% EFF 0.030 +20.0% W 0.500 +1.0% RDG 0.160 +0.0% ARIC 0.780 +4.0% VROY 3.44 +5.2% ROCK 3.81 +3.0% APMI 0.120 +0.0% EM 3.58 −4.8% ALS 66.04 +6.8% MEK 0.065 +44.4% TLO 6.00 +13.0% ADE 0.045 −66.7% FAIR 0.060 +33.3% SVRS 0.420 −2.3% RES 0.050 +42.9% CYG 0.120 +0.0%

Healthcare

Page 66
  1. Feb 03, 2026 · 19:23 · OTC

    Ocumetics has positive intraocular lens results

    Ocumetics has positive intraocular lens results

    01
  2. Feb 03, 2026 · 16:31 · MRVL

    Marvel Biosciences Receives Japanese Patent Covering Composition of Matter for Its Lead Therapeutic Candidate MB-204

    Marvel Biosciences Receives Japanese Patent Covering Composition of Matter for Its Lead Therapeutic Candidate MB-204

    02
  3. Feb 03, 2026 · 15:22 · LOBE

    Lobe Sciences' Nov. 30 cash at $5.99-million

    Lobe Sciences' Nov. 30 cash at $5.99-million

    03
  4. Feb 03, 2026 · 08:56 · HEM

    Hemostemix Appoints Renowned Vascular Surgeon and Principal Investigator, Dr. York Hsiang, as Business Consultant to Advance First Nations-Led Healthcare Partnerships

    Hemostemix Appoints Renowned Vascular Surgeon and Principal Investigator, Dr. York Hsiang, as Business Consultant to Advance First Nations-Led Healthcare Partnerships

    04
  5. Feb 03, 2026 · 08:50 · OTC

    Ocumetics Reports Positive Three Month First-in-Human Results, Significantly De-Risking Its Accommodating Intraocular Lens Technology

    Ocumetics Reports Positive Three Month First-in-Human Results, Significantly De-Risking Its Accommodating Intraocular Lens Technology

    05
  6. Feb 03, 2026 · 07:00 · LOBE

    Lobe Sciences Reports First Quarter 2026 Results and Highlights

    Lobe Sciences Reports First Quarter 2026 Results and Highlights

    06
  7. Feb 02, 2026 · 21:05 · MDX

    MedX Health arranges $5-million note financing

    MedX Health arranges $5-million note financing

    07
  8. Feb 02, 2026 · 19:08 · PHRM

    Pharmather seeks to commercialize generic semaglutide

    Pharmather seeks to commercialize generic semaglutide

    08
  9. Feb 02, 2026 · 18:21 · SEGN

    Seegnal Expands Deployment of Seegnal's Prescription Intelligence Platform at Tel Aviv Sourasky Medical Center, a Leading Israeli Public Medical Center and Global Referral Center

    Seegnal Expands Deployment of Seegnal's Prescription Intelligence Platform at Tel Aviv Sourasky Medical Center, a Leading Israeli Public Medical Center and Global Referral Center

    09
  10. Feb 02, 2026 · 17:46 · MBIO

    Mindbio pitches AI voice drug tests to miners

    Mindbio pitches AI voice drug tests to miners

    10
  11. Feb 02, 2026 · 17:38 · NURS

    Hydreight estimates 2026 revenue of $150-million

    Hydreight estimates 2026 revenue of $150-million

    11
  12. Feb 02, 2026 · 17:01 · MDX

    MedX Announces Non-Brokered Private Placement of Series IV Convertible Loan Notes

    MedX Announces Non-Brokered Private Placement of Series IV Convertible Loan Notes

    12
  13. Feb 02, 2026 · 16:25 · TLT

    Theralase treats 90 patients in bladder cancer study

    Theralase treats 90 patients in bladder cancer study

    13
  14. Feb 02, 2026 · 14:22 · NLH

    Nova Leap sets up palliative care division in N.S.

    Nova Leap sets up palliative care division in N.S.

    14
← Newer Older →